Human Apolipoprotein E4 Targeted Replacement Mice Show Increased Prevalence of Intracerebral Hemorrhage Associated with Vascular Amyloid Deposition

Patrick M. Sullivan, Brian E. Mace, Januario C. Estrada, Donald E. Schmechel, Mark J. Alberts

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Previous studies show that APOE*4 carriers are at increased risk for ischemic stroke and intracerebral hemorrhage (ICH). The APOE*4 gene is also linked to increased incidence of cerebral amyloid angiopathy. It has been suggested that apolipoprotein E4 expression leads to increased vascular amyloid deposition, which may explain the increased incidence of ICH in APOE*4 carriers. Here we show a significant increase in ICH in apoE4 targeted replacement mice compared with apoE3 mice. In all, 89% of the vessels in the apoE4 mice that showed evidence for hemorrhage contained fibrillar amyloid beta based on thioflavine-S staining. Aged apoE4 mice contained predominantly vascular amyloid deposits in the frontal cortex and hippocampus, but also showed evidence for parenchymal amyloid deposits. Most of the parenchymal amyloid appeared diffuse in nature; however, a small fraction was thioflavine-S positive, indicating presence of fibrillar amyloid. Electron microscopy further revealed evidence for fibrillar deposits in the vessel walls of apoE4 mice, but not apoE3 mice. The apoE4 targeted replacement mice do not harbor any mutation in the amyloid precursor protein gene and, therefore, are similar to the majority of humans susceptible to cerebral amyloid angiopathy and ICH, where the APOE genetic polymorphism is the only known genetic risk factor.

Original languageEnglish (US)
Pages (from-to)303-311
Number of pages9
JournalJournal of Stroke and Cerebrovascular Diseases
Volume17
Issue number5
DOIs
StatePublished - Sep 2008

Fingerprint

Apolipoprotein E4
Cerebral Hemorrhage
Amyloid
Blood Vessels
Apolipoprotein E3
Cerebral Amyloid Angiopathy
Amyloid Plaques
Amyloid beta-Protein Precursor
Incidence
Frontal Lobe
Genetic Polymorphisms
Genes
Hippocampus
Electron Microscopy
Stroke
Staining and Labeling
Hemorrhage
Mutation

Keywords

  • amyloid
  • Apolipoprotein E
  • dementia
  • hemorrhage
  • mice

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery
  • Health Professions(all)

Cite this

Human Apolipoprotein E4 Targeted Replacement Mice Show Increased Prevalence of Intracerebral Hemorrhage Associated with Vascular Amyloid Deposition. / Sullivan, Patrick M.; Mace, Brian E.; Estrada, Januario C.; Schmechel, Donald E.; Alberts, Mark J.

In: Journal of Stroke and Cerebrovascular Diseases, Vol. 17, No. 5, 09.2008, p. 303-311.

Research output: Contribution to journalArticle

@article{3f536a52eb2c4acd827c8483ae243c66,
title = "Human Apolipoprotein E4 Targeted Replacement Mice Show Increased Prevalence of Intracerebral Hemorrhage Associated with Vascular Amyloid Deposition",
abstract = "Previous studies show that APOE*4 carriers are at increased risk for ischemic stroke and intracerebral hemorrhage (ICH). The APOE*4 gene is also linked to increased incidence of cerebral amyloid angiopathy. It has been suggested that apolipoprotein E4 expression leads to increased vascular amyloid deposition, which may explain the increased incidence of ICH in APOE*4 carriers. Here we show a significant increase in ICH in apoE4 targeted replacement mice compared with apoE3 mice. In all, 89{\%} of the vessels in the apoE4 mice that showed evidence for hemorrhage contained fibrillar amyloid beta based on thioflavine-S staining. Aged apoE4 mice contained predominantly vascular amyloid deposits in the frontal cortex and hippocampus, but also showed evidence for parenchymal amyloid deposits. Most of the parenchymal amyloid appeared diffuse in nature; however, a small fraction was thioflavine-S positive, indicating presence of fibrillar amyloid. Electron microscopy further revealed evidence for fibrillar deposits in the vessel walls of apoE4 mice, but not apoE3 mice. The apoE4 targeted replacement mice do not harbor any mutation in the amyloid precursor protein gene and, therefore, are similar to the majority of humans susceptible to cerebral amyloid angiopathy and ICH, where the APOE genetic polymorphism is the only known genetic risk factor.",
keywords = "amyloid, Apolipoprotein E, dementia, hemorrhage, mice",
author = "Sullivan, {Patrick M.} and Mace, {Brian E.} and Estrada, {Januario C.} and Schmechel, {Donald E.} and Alberts, {Mark J.}",
year = "2008",
month = "9",
doi = "10.1016/j.jstrokecerebrovasdis.2008.03.011",
language = "English (US)",
volume = "17",
pages = "303--311",
journal = "Journal of Stroke and Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Human Apolipoprotein E4 Targeted Replacement Mice Show Increased Prevalence of Intracerebral Hemorrhage Associated with Vascular Amyloid Deposition

AU - Sullivan, Patrick M.

AU - Mace, Brian E.

AU - Estrada, Januario C.

AU - Schmechel, Donald E.

AU - Alberts, Mark J.

PY - 2008/9

Y1 - 2008/9

N2 - Previous studies show that APOE*4 carriers are at increased risk for ischemic stroke and intracerebral hemorrhage (ICH). The APOE*4 gene is also linked to increased incidence of cerebral amyloid angiopathy. It has been suggested that apolipoprotein E4 expression leads to increased vascular amyloid deposition, which may explain the increased incidence of ICH in APOE*4 carriers. Here we show a significant increase in ICH in apoE4 targeted replacement mice compared with apoE3 mice. In all, 89% of the vessels in the apoE4 mice that showed evidence for hemorrhage contained fibrillar amyloid beta based on thioflavine-S staining. Aged apoE4 mice contained predominantly vascular amyloid deposits in the frontal cortex and hippocampus, but also showed evidence for parenchymal amyloid deposits. Most of the parenchymal amyloid appeared diffuse in nature; however, a small fraction was thioflavine-S positive, indicating presence of fibrillar amyloid. Electron microscopy further revealed evidence for fibrillar deposits in the vessel walls of apoE4 mice, but not apoE3 mice. The apoE4 targeted replacement mice do not harbor any mutation in the amyloid precursor protein gene and, therefore, are similar to the majority of humans susceptible to cerebral amyloid angiopathy and ICH, where the APOE genetic polymorphism is the only known genetic risk factor.

AB - Previous studies show that APOE*4 carriers are at increased risk for ischemic stroke and intracerebral hemorrhage (ICH). The APOE*4 gene is also linked to increased incidence of cerebral amyloid angiopathy. It has been suggested that apolipoprotein E4 expression leads to increased vascular amyloid deposition, which may explain the increased incidence of ICH in APOE*4 carriers. Here we show a significant increase in ICH in apoE4 targeted replacement mice compared with apoE3 mice. In all, 89% of the vessels in the apoE4 mice that showed evidence for hemorrhage contained fibrillar amyloid beta based on thioflavine-S staining. Aged apoE4 mice contained predominantly vascular amyloid deposits in the frontal cortex and hippocampus, but also showed evidence for parenchymal amyloid deposits. Most of the parenchymal amyloid appeared diffuse in nature; however, a small fraction was thioflavine-S positive, indicating presence of fibrillar amyloid. Electron microscopy further revealed evidence for fibrillar deposits in the vessel walls of apoE4 mice, but not apoE3 mice. The apoE4 targeted replacement mice do not harbor any mutation in the amyloid precursor protein gene and, therefore, are similar to the majority of humans susceptible to cerebral amyloid angiopathy and ICH, where the APOE genetic polymorphism is the only known genetic risk factor.

KW - amyloid

KW - Apolipoprotein E

KW - dementia

KW - hemorrhage

KW - mice

UR - http://www.scopus.com/inward/record.url?scp=49949103769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49949103769&partnerID=8YFLogxK

U2 - 10.1016/j.jstrokecerebrovasdis.2008.03.011

DO - 10.1016/j.jstrokecerebrovasdis.2008.03.011

M3 - Article

C2 - 18755411

AN - SCOPUS:49949103769

VL - 17

SP - 303

EP - 311

JO - Journal of Stroke and Cerebrovascular Diseases

JF - Journal of Stroke and Cerebrovascular Diseases

SN - 1052-3057

IS - 5

ER -